Metastatic Castration-resistant Prostate Cancer (mCRPC)
Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
NovartisBASEL, Switzerland
2 programs2
AAA617Phase 21 trial
[177Lu]Lu-PSMA-617Phase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
NovartisAAA617
MediLink TherapeuticsYL201 for Injection
Novartis[177Lu]Lu-PSMA-617
Clinical Trials (3)
Total enrollment: 82 patients across 3 trials
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
Start: Apr 2024Est. completion: Jun 202620 patients
Phase 2Recruiting
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
Start: Feb 2024Est. completion: Feb 2029
Phase 2Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC
Start: May 2023Est. completion: Jun 202662 patients
Phase 2Active Not Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
15m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
15m ago
Office Administrator
SystImmune
15m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
25m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
29m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
29m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 82 patients
2 companies competing in this space